Table 3 Crude and age-adjusted prevalence rates of anti-HEV IgM and anti-HEV IgG among control group, HIV-positive subjects living inside and outside Kathmandu
From: Prevalence and risk of hepatitis E virus infection in the HIV population of Nepal
HIV (total) | Blood donors | HIV (Kathmandu) | HIV (Outside Kathmandu) | ||
|---|---|---|---|---|---|
Anti-HEV IgM | Crude prevalence rate | 15.31 | 4.64 | 28.93 | 4.9 |
Age adjusted prevalence rate | 17.54 | 3.6 | 30.61 | 4.21 | |
Anti-HEV IgG | Crude prevalence rate | 39.60 | 9.63 | 77.8 | 23.6 |
Age adjusted prevalence rate | 35.02 | 8.3 | 65.89 | 20.84 |